Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Autologously Humanized Mice for Immune‐Oncologic Studies

Current Protocols in Pharmacology(2020)10.1002/cpph.76Source: DataRank Database

Autologously Humanized Mice for Immune‐Oncologic Studies is a research paper published in Current Protocols in Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.40)OA: greenTopics (71)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Young J. Kim ORCID,Juan Fu

Live enrichment

PubMed:32469451 PMC:PMC9710199 OpenAlex:https://openalex.org/W3031717648

National Science Foundation

Grant: R01 CA178613

National Science Foundation

Grant: R01 DE027749

BLRD VA

Grant: I01 BX006010

National Institutes of Health

Grant: 5R01DE027749-05

Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting

National Institutes of Health

Grant: 4R01CA178613-04

Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer

Congressionally Directed Medical Research Programs

FWCI

0.40

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2025

2026

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9710199

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710199

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9710199

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cpph.76

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cpph.76

Fields of Study

Immunotherapy and Immune ResponsesCancer Research and TreatmentsImmune cells in cancerMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsBone Marrow CellsBone Marrow TransplantationCells, CulturedDisease Models, AnimalFemaleHematopoietic Stem CellsHeterograftsHumansImmune Checkpoint InhibitorsMaleMiceMice, Inbred NODMice, SCIDMyeloid CellsNeoplasmsTumor MicroenvironmentXenograft Model Antitumor Assays

MeSH Terms

Immune Checkpoint InhibitorsAnimalsBone Marrow CellsCells, CulturedDisease Models, AnimalFemaleHematopoietic Stem CellsHumansMaleNeoplasmsBone Marrow TransplantationMice, SCIDMice, Inbred NODMyeloid CellsXenograft Model Antitumor AssaysMiceTumor MicroenvironmentHeterografts

Keywords

Humanized mouseImmune systemImmunologyComputational biologyMedicineBiologyTumor MicroenvironmentHumanized MiceAutologous ReconstitutionHead Neck CarcinomaMaleBone Marrow CellsMice, SCIDHematopoietic Stem CellsXenograft Model Antitumor AssaysDisease Models, AnimalMiceMice, Inbred NODNeoplasmsAnimalsHeterograftsHumansFemaleMyeloid CellsImmune Checkpoint InhibitorsCells, CulturedBone Marrow Transplantation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being